Aspen Aerogels (ASPN) Projected to Release Quarterly Earnings on Thursday

Posted by George Bondi on Aug 4th, 2026

Aspen Aerogels (NYSE:ASPN – Get Free Report) is expected to post its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to post earnings of ($0.2275) per share and revenue of $42.4220 million for the quarter. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. Parties can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:30 AM ET.

Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its earnings results on Thursday, May 7th. The construction company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The company had revenue of $37.88 million for the quarter, compared to analysts’ expectations of $36.58 million. Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The company’s revenue was down 51.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.06) earnings per share. On average, analysts expect Aspen Aerogels to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Aspen Aerogels Trading Up 5.7%

Shares of NYSE:ASPN traded up $0.27 during trading on Tuesday, reaching $5.00. 117,452 shares of the company traded hands, compared to its average volume of 1,510,250. The firm has a market capitalization of $414.32 million, a price-to-earnings ratio of -3.67 and a beta of 2.99. Aspen Aerogels has a 52-week low of $2.30 and a 52-week high of $9.78. The company has a current ratio of 2.89, a quick ratio of 2.54 and a debt-to-equity ratio of 0.32. The business’s fifty day moving average is $5.55 and its 200-day moving average is $4.37.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors have recently modified their holdings of the stock. Royal Bank of Canada lifted its stake in Aspen Aerogels by 84.7% during the 1st quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock valued at $360,000 after acquiring an additional 25,880 shares during the period. AQR Capital Management LLC bought a new stake in shares of Aspen Aerogels in the first quarter worth approximately $960,000. Integrated Wealth Concepts LLC bought a new stake in shares of Aspen Aerogels in the first quarter worth approximately $84,000. Goldman Sachs Group Inc. raised its holdings in shares of Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after purchasing an additional 602,586 shares during the last quarter. Finally, Caxton Associates LLP bought a new position in Aspen Aerogels during the first quarter valued at approximately $307,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ASPN has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Barclays raised their target price on Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a research note on Monday, May 11th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Finally, Roth Capital reiterated a “buy” rating and issued a $5.75 price objective on shares of Aspen Aerogels in a report on Friday, May 8th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Hold” and a consensus price target of $5.19.

Check Out Our Latest Report on Aspen Aerogels

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.